Details

Last Funding Type

Series Unknown

Last Funding Money Raised

€23M

Industries

Biotechnology,Genetics,Health Care,Medical,Therapeutics

Founded date

Jan 1, 2002

Number Of Employee

11 - 50

Operating Status

Active

Prosensa is a biotech company also known as Ribpharm Inc dedicated to the commercialization of products for the healthcare market based on RNA-based therapeutics.

During the development of this technology, it became clear that many opportunities exist for the development of these products into novel commercially attractive products. These products are mainly in the field of genetic disorders, anti-infectives and oncology.

Prosensa will focus to maximize the commercial development of the current program, and take advantage of the large novel market opportunities supported by a strong IP position. Prosensa will initially operate mainly as a focussed company, outsourcing most of its activities to specialized organizations.